# Revuforj

NDC: 73555-501
Generic name: revumenib
Labeler / Manufacturer: Syndax Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20241115

FDA application: NDA218944

## Active ingredients

- REVUMENIB CITRATE: 110 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"73555-501"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=73555-501
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6eb3cdbc-0e74-477d-82d6-3bb172d3f63f